Dr Jane Margetts
Dr Louise Li
| Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England | 2015 |
|
Dr Albiruni Abdul Razak
Dr Louise Li
Andrew Bryant
| Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease | 2011 |
|
Dr Louise Li
| Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option? | 2009 |
|
Professor Ruth Plummer
Dr Louise Li
Rebecca Perrett
Professor Alan Calvert
| Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers | 2007 |
|
Professor Ruth Plummer
Dr Louise Li
Rebecca Perrett
Professor Alan Calvert
| Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumours with mutated EGFR | 2006 |
|
